BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33648892)

  • 1. Reporting of dose-volume specifications for "Martinez Universal Perineal Interstitial Template-based interstitial high-dose-rate brachytherapy for gynecological cancers" according to International Commission on Radiation Units and Measurements 58 with early clinical outcomes.
    Sood S; Gurram L; Aravindakshan D; Paul J; Chopra S; Swamidas J; Patil A; Mahantshetty U
    Brachytherapy; 2021; 20(3):550-556. PubMed ID: 33648892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric Comparison of Isodose Surface Volume and Total Reference Air Kerma (TRAK) based Volume in Cervical Cancer Brachytherapy.
    Thimmaiah N; Malavade V; A S UK; S S; Pasha C R T; Vishwanath L
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):587-594. PubMed ID: 38415545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total reference air kerma: to what extent can it predict intracavitary volume enclosed by isodose surfaces during multiple high-dose rate brachytherapy?
    Datta NR; Das KJ; Basu R; Singh U
    Brachytherapy; 2003; 2(2):91-7. PubMed ID: 15062146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between revised Manchester Point A and ICRU-89-recommended Point A definition absorbed-dose reporting using CT images in intracavitary brachytherapy for patients with cervical carcinoma.
    Mourya A; Choudhary S; Shahi UP; Sharma N; Gautam H; Patel G; Pradhan S; Aggarwal LM
    Brachytherapy; 2021; 20(1):118-127. PubMed ID: 32811759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculation of dose volume parameters and indices in plan evaluation of HDR interstitial brachytherapy by MUPIT in carcinoma cervix.
    Poddar J; Sharma AD; Suryanarayan U; Shah SP; Parikh A; Mehta V; Kumar T
    Indian J Cancer; 2018; 55(3):238-241. PubMed ID: 30693886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mathematical model to predict the different isodose volumes using TRAK value in HDR intracavitary brachytherapy for revised Manchester and ICRU-89 based Point A plans using computer tomography images.
    Mourya A; Choudhary S; Sharma N; Shahi UP; Singh G; Pradhan S; Aggarwal LM
    J Cancer Res Ther; 2022; 18(4):1105-1113. PubMed ID: 36149168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total reference air kerma can accurately predict isodose surface volumes in cervix cancer brachytherapy. A multicenter study.
    Nkiwane KS; Andersen E; Champoudry J; de Leeuw A; Swamidas J; Lindegaard J; Pötter R; Kirisits C; Tanderup K
    Brachytherapy; 2017; 16(6):1184-1191. PubMed ID: 28867617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies.
    Gupta AK; Vicini FA; Frazier AJ; Barth-Jones DC; Edmundson GK; Mele E; Gustafson GS; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1055-60. PubMed ID: 10192355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy.
    Pötter R; Van Limbergen E; Gerstner N; Wambersie A
    Radiother Oncol; 2001 Jan; 58(1):11-8. PubMed ID: 11165676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can combined intracavitary/interstitial approach be an alternative to interstitial brachytherapy with the Martinez Universal Perineal Interstitial Template (MUPIT) in computed tomography-guided adaptive brachytherapy for bulky and/or irregularly shaped gynecological tumors?
    Oike T; Ohno T; Noda SE; Kiyohara H; Ando K; Shibuya K; Tamaki T; Takakusagi Y; Sato H; Nakano T
    Radiat Oncol; 2014 Oct; 9():222. PubMed ID: 25319341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Template-based high-dose-rate interstitial brachytherapy in gynecologic cancers: a single institutional experience.
    Mahantshetty U; Shrivastava S; Kalyani N; Banerjee S; Engineer R; Chopra S
    Brachytherapy; 2014; 13(4):337-42. PubMed ID: 24176863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
    Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
    Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose optimization in gynecological 3D image based interstitial brachytherapy using martinez universal perineal interstitial template (MUPIT) -an institutional experience.
    Sharma PK; Sharma PK; Swamidas JV; Mahantshetty U; Deshpande DD; Manjhi J; Rai DV
    J Med Phys; 2014 Jul; 39(3):197-202. PubMed ID: 25190999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
    Hung J; Shen S; De Los Santos JF; Kim RY
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
    Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of total reference air-kerma (TRAK) to prescription isodose surface volume in vaginal cylinder high-dose-rate brachytherapy.
    Yaparpalvi R; Mehta KJ
    J Contemp Brachytherapy; 2021 Aug; 13(4):447-450. PubMed ID: 34484360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of freehand interstitial brachytherapy in advanced gynecologic malignancies.
    Bajwa HK; Singareddy R; Krishnam Raju A
    Brachytherapy; 2020; 19(5):669-673. PubMed ID: 32466952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.